Key Insights

Highlights

Success Rate

67% trial completion

Treatment Research

13 treatments under study, led by New Generation Ehf

Research Leaders

7 sponsors active, led by Société des Produits Nestlé (SPN)

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

12.5%

1 terminated out of 8 trials

Success Rate

66.7%

-19.9% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

67% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (7)

Trial Status

Not Yet Recruiting3
Completed2
Recruiting1
Terminated1
Enrolling By Invitation1

Trial Success Rate

66.7%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (8)

Research Network

Common Treatments

  • New Generation Ehf2
  • Commercial Ehf2
  • Dietary Intervention Using Cookies Containing Milk Or Egg Low Dose1
  • Partially Hydrolysed Whey Based Formula1
  • Control Formula1

Active Sponsors

  • Société des Produits Nestlé (SPN)3
  • Kasr El Aini Hospital1
  • Ain Shams University1
  • Fundació Sant Joan de Déu1
  • Hospital Sant Joan de Deu1

Top Investigators

Related Conditions

  • Cow Milk Intolerance1
  • Hen Egg Allergy1
  • Immunoglobulin A1
  • Mucin1
  • Fpies1

Activity Timeline